Annual Book Value
$59.08 M
-$141.73 M-70.58%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual book value is $59.08 million, with the most recent change of -$141.73 million (-70.58%) on December 31, 2024.
- During the last 3 years, TVTX annual book value has fallen by -$243.03 million (-80.45%).
- TVTX annual book value is now -81.44% below its all-time high of $318.25 million, reached on December 31, 2018.
Performance
TVTX Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$59.08 M
+$89.53 M+293.99%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly book value is $59.08 million, with the most recent change of +$89.53 million (+293.99%) on December 1, 2024.
- Over the past year, TVTX quarterly book value has dropped by -$141.73 million (-70.58%).
- TVTX quarterly book value is now -83.71% below its all-time high of $362.69 million, reached on March 31, 2021.
Performance
TVTX Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
TVTX Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.6% | -70.6% |
| 3 y3 years | -80.5% | -70.6% |
| 5 y5 years | -73.3% | -70.6% |
TVTX Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.5% | +37.9% | -80.5% | +294.0% |
| 5 y | 5-year | -80.5% | +37.9% | -83.7% | +294.0% |
| alltime | all time | -81.4% | +258.6% | -83.7% | +258.6% |
Travere Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $59.08 M(-70.6%) | - |
| Dec 2024 | - | $59.08 M(-294.0%) |
| Sep 2024 | - | -$30.45 M(-301.1%) |
| Jun 2024 | - | $15.15 M(-79.6%) |
| Mar 2024 | - | $74.07 M(-63.1%) |
| Dec 2023 | $200.81 M(+368.6%) | $200.81 M(-28.2%) |
| Sep 2023 | - | $279.77 M(+140.2%) |
| Jun 2023 | - | $116.48 M(-38.4%) |
| Mar 2023 | - | $189.14 M(+341.4%) |
| Dec 2022 | $42.85 M(-85.8%) | $42.85 M(-57.4%) |
| Sep 2022 | - | $100.68 M(-35.8%) |
| Jun 2022 | - | $156.71 M(-24.7%) |
| Mar 2022 | - | $208.14 M(-31.1%) |
| Dec 2021 | $302.11 M(+43.0%) | $302.11 M(-1.7%) |
| Sep 2021 | - | $307.37 M(-7.5%) |
| Jun 2021 | - | $332.30 M(-8.4%) |
| Mar 2021 | - | $362.69 M(+71.7%) |
| Dec 2020 | $211.21 M(-4.5%) | $211.21 M(-29.9%) |
| Sep 2020 | - | $301.41 M(-5.4%) |
| Jun 2020 | - | $318.64 M(+41.2%) |
| Mar 2020 | - | $225.75 M(+2.1%) |
| Dec 2019 | $221.20 M(-30.5%) | $221.20 M(-10.1%) |
| Sep 2019 | - | $245.96 M(-11.2%) |
| Jun 2019 | - | $277.09 M(-3.0%) |
| Mar 2019 | - | $285.71 M(-10.2%) |
| Dec 2018 | $318.25 M(+8.6%) | $318.25 M(-0.3%) |
| Sep 2018 | - | $319.06 M(+10.8%) |
| Jun 2018 | - | $287.99 M(-3.8%) |
| Mar 2018 | - | $299.48 M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $293.13 M(-4.8%) | $293.13 M(-3.7%) |
| Sep 2017 | - | $304.52 M(+2.9%) |
| Jun 2017 | - | $295.83 M(-1.7%) |
| Mar 2017 | - | $300.94 M(-2.2%) |
| Dec 2016 | $307.77 M(+2.6%) | $307.77 M(+0.1%) |
| Sep 2016 | - | $307.60 M(-2.2%) |
| Jun 2016 | - | $314.37 M(-1.5%) |
| Mar 2016 | - | $319.23 M(+6.4%) |
| Dec 2015 | $299.97 M(-905.3%) | $299.97 M(+3.1%) |
| Sep 2015 | - | $291.01 M(+93.0%) |
| Jun 2015 | - | $150.78 M(-10.6%) |
| Mar 2015 | - | $168.57 M(-552.5%) |
| Dec 2014 | -$37.25 M(+89.4%) | -$37.25 M(+265.6%) |
| Sep 2014 | - | -$10.19 M(-1055.0%) |
| Jun 2014 | - | $1.07 M(-103.0%) |
| Mar 2014 | - | -$35.39 M(+80.0%) |
| Dec 2013 | -$19.67 M(+477.1%) | -$19.67 M(+238.8%) |
| Sep 2013 | - | -$5.80 M(-31.4%) |
| Jun 2013 | - | -$8.46 M(+162.5%) |
| Mar 2013 | - | -$3.22 M(+4871.8%) |
| Dec 2012 | -$3.41 M(+5300.6%) | - |
| Nov 2012 | - | -$64.80 K(+1.1%) |
| Aug 2012 | - | -$64.10 K(+0.8%) |
| May 2012 | - | -$63.60 K(+0.8%) |
| Feb 2012 | - | -$63.10 K(+2.1%) |
| Feb 2012 | -$63.10 K(+4.6%) | - |
| Nov 2011 | - | -$61.80 K(+0.8%) |
| Aug 2011 | - | -$61.30 K(+1.7%) |
| Feb 2011 | -$60.30 K | -$60.30 K |
FAQ
- What is Travere Therapeutics annual book value?
- What is the all time high annual book value for Travere Therapeutics?
- What is Travere Therapeutics annual book value year-on-year change?
- What is Travere Therapeutics quarterly book value?
- What is the all time high quarterly book value for Travere Therapeutics?
- What is Travere Therapeutics quarterly book value year-on-year change?
What is Travere Therapeutics annual book value?
The current annual book value of TVTX is $59.08 M
What is the all time high annual book value for Travere Therapeutics?
Travere Therapeutics all-time high annual book value is $318.25 M
What is Travere Therapeutics annual book value year-on-year change?
Over the past year, TVTX annual book value has changed by -$141.73 M (-70.58%)
What is Travere Therapeutics quarterly book value?
The current quarterly book value of TVTX is $59.08 M
What is the all time high quarterly book value for Travere Therapeutics?
Travere Therapeutics all-time high quarterly book value is $362.69 M
What is Travere Therapeutics quarterly book value year-on-year change?
Over the past year, TVTX quarterly book value has changed by -$141.73 M (-70.58%)